![]() |
市场调查报告书
商品编码
1784640
欧洲雷射辅助耳鼻喉手术市场报告(2021-2031 年,范围、细分、动态和竞争分析)Europe Laser-Assisted ENT Surgery Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
欧洲雷射辅助耳鼻喉手术市场规模预计将从 2023 年的 58,880.47 千美元增加到 2031 年的 109,469.65 千美元。预计 2023 年至 2031 年期间该市场的复合年增长率为 8.1%。
执行摘要和欧洲雷射辅助耳鼻喉手术市场分析:
英国政府正在采取措施,推动包括耳鼻喉雷射系统在内的先进技术的整合,以增强医疗服务并改善患者预后。英国国家医疗服务体系 (NHS) 已认识到雷射技术因其精准性和微创性,在各种耳鼻喉科手术中的潜力。这与 NHS 旨在减少等待时间和提高手术治疗可及性的更广泛努力相一致。 Neomed UK 推出了 Nuvolas GREEN ENT 雷射设备,其工作波长为 514 nm,在临床应用中表现出色,尤其适用于需要高精度和充分止血的手术。该雷射能够汽化组织,同时对周围区域的损伤极小,对于希望改善患者预后和缩短康復时间的耳鼻喉科专家来说,它是一个颇具吸引力的选择。
欧洲雷射辅助耳鼻喉手术市场細項分析:
有助于得出雷射辅助耳鼻喉手术市场分析的关键部分是雷射类型、手术类型和最终用户。
根据雷射类型,雷射辅助耳鼻喉手术市场细分为二氧化碳雷射、Nd.YAG雷射、二极体雷射、蓝光雷射、KTP雷射、氩雷射和其他雷射类型。二氧化碳雷射在2023年占据了最大的市场份额。
就手术类型而言,雷射辅助耳鼻喉手术市场分为雷射喉部手术、雷射内视镜鼻窦手术(较少)、雷射辅助悬雍垂腭咽成形术 (LAUP)、雷射辅助镫骨切开术、雷射辅助扁桃体切除术和腺样体切除术、雷射鼻甲缩小术、经口雷射显微手术 (TLM)、鼻腔手术和其他手术类型。 2023 年,雷射辅助扁桃体切除术和腺样体切除术占据了最大的市场份额。
根据最终用户,雷射辅助耳鼻喉手术市场可分为医院和专科诊所、医生办公室和其他最终用户。医院和专科诊所在2023年占据了最大的市场。
欧洲雷射辅助耳鼻喉手术市场展望
随着全球医疗保健系统日益重视门诊治疗,外科手术的格局也不断演变,雷射辅助手术逐渐成为许多耳鼻喉疾病的首选治疗方案。这种转变受多种因素驱动,包括医疗技术的进步、患者对便利性和缩短復原时间的偏好,以及门诊手术的经济效益。
二氧化碳 (CO2) 雷射和 Nd:YAG 雷射等雷射广泛应用于各种耳鼻喉手术,包括治疗慢性鼻窦炎、扁桃体切除术和肿瘤切除术。这些雷射器能够精准定位组织,最大限度地减少对周围区域的损伤,并显着减少术后併发症。因此,许多曾经需要住院的手术现在可以在门诊进行,这与人们对微创技术的日益青睐相一致。
由于门诊手术有许多优势,越来越多的患者选择门诊手术。门诊手术通常恢復时间较短,患者能够更快恢復日常生活。这在快节奏的时代尤其具有吸引力,因为人们往往不愿意为了接受手术而长时间休假或中断个人生活。雷射辅助手术恢復期短、併发症风险低,完美契合了这项需求。患者能够在当天接受治疗并回家,这提升了他们的整体体验和对医疗保健系统的满意度。
此外,医疗政策和报销模式的变化也影响着人们向门诊手术的转变。如今,许多保险公司更青睐门诊手术,因为门诊手术成本效益高,且病患治疗效果良好。报销策略的这种转变鼓励医疗保健机构采用雷射辅助技术,因为它们既能提供高品质的护理,又能满足保险公司设定的经济激励措施。随着报销政策的演变,雷射辅助耳鼻喉手术市场有望受益于此类手术的普及和使用率的提高。
因此,对门诊手术的需求不断增长对雷射辅助耳鼻喉手术市场产生了积极影响。
欧洲雷射辅助耳鼻喉手术市场国家洞察
根据地理划分,欧洲雷射辅助耳鼻喉手术市场包括英国、德国、法国、西班牙、义大利和欧洲其他地区。 2023年,德国占最大份额。
在德国,雷射手术正日益成为治疗各种耳鼻喉疾病的首选方案。将先进的雷射技术融入耳鼻咽喉科,彻底改变了外科手术的实践,为患者提供了微创的替代方案,从而加快了康復速度并减少了併发症。 Biolitec 是德国领先的创新雷射系统研发公司之一,专为耳鼻咽喉应用而设计。其 LEONARDO Mini Dual 和 LEONARDO Mini Blue 雷射为头部颈部的各种手术提供了多功能解决方案。这些雷射利用不同的波长来达到最佳效果,可以精确切除组织并有效治疗耳鼻喉疾病,包括肿瘤和慢性鼻窦炎。
欧洲雷射辅助耳鼻喉手术市场公司概况
市场上的一些主要参与者包括 biolitec AG (Biolitec)、Iridex Corporation、Medency、Dimed Laser Technology Co., Ltd.、intros Medical Laser GmbH、ARC Laser GmbH、LightScalpel、GIGAAMEDICAL、INTERmedic ARFRAN、Limmer Laser GmbH、Qolight这些参与者正在采用扩张、产品创新和併购等各种策略,为消费者提供创新产品并增加市场份额。
欧洲雷射辅助耳鼻喉手术市场研究方法:
本报告中的资料收集和分析遵循了以下方法:
二手资料研究:研究流程始于全面的二手资料研究,利用内部和外部资源收集每个市场的定性和定量资料。常用的二手资料研究来源包括但不限于:
公司网站、年度报告、财务报表、经纪商分析和投资者介绍。行业期刊及其他相关出版品。政府文件、统计资料库和市场报告。针对在市场运营的公司的新闻文章、新闻稿和网路广播。註:公司简介部分所包含的所有财务资料均已标准化为美元。对于以其他货币报告的公司,数据已使用相应年份的相关汇率转换为美元。
一手研究 Insight Partners 每年都会与行业利益相关者和专家进行大量的一手调查,以验证其资料分析,并获得宝贵的见解。这些研究访谈旨在:
验证并完善二手资料研究的结果。提升分析团队的专业知识和市场理解。深入了解市场规模、趋势、成长模式、竞争动态和未来前景。一手资料研究透过电子邮件互动和电话访谈进行,涵盖不同地区的各种市场、类别、细分市场和次细分市场。参与者通常包括:
产业利害关係人:副总裁、业务发展经理、市场情报经理和国家销售经理外部专家:估值专家、研究分析师和具有行业专业知识的关键意见领袖
The Europe Laser-Assisted ENT Surgery Market size is expected to reach US$ 109,469.65 thousand by 2031 from US$ 58,880.47 thousand in 2023. The market is estimated to record a CAGR of 8.1% from 2023 to 2031.
Executive Summary and Europe Laser-Assisted ENT Surgery Market Analysis:
In the UK, the government is taking initiatives to prompt the integration of advanced technologies, including ENT laser systems, to enhance healthcare delivery and improve patient outcomes. The National Health Service (NHS) has recognized the potential of laser technology in various otolaryngology procedures owing to its precision and minimally invasive nature. This aligns with the NHS' broader efforts to reduce waiting times and improve access to surgical treatments. Neomed UK has launched the Nuvolas GREEN ENT laser device that operates at a wavelength of 514 nm, providing excellent performance in clinical applications, particularly for procedures requiring high precision and adequate hemostasis. The laser's ability to vaporize tissue with minimal damage to surrounding areas makes it an attractive option for ENT specialists looking to improve patient outcomes and reduce recovery times.
Europe Laser-Assisted ENT Surgery Market Segmentation Analysis:
Key segments that contributed to the derivation of the laser-assisted ENT surgery market analysis are laser type, surgery type, and end user.
By laser type, the laser-assisted ENT surgery market is segmented into CO2laser, Nd.YAGlaser, diode laser, blue laser, KTP laser, argon laser, and other laser types. The CO2laser held the largest share of the market in 2023.
In terms of surgery type, the laser-assisted ENT surgery market is divided into laser laryngeal surgery, laser endoscopic sinus surgery (less), laser-assisted uvulopalatoplasty (LAUP), laser-assisted stapedotomy, laser-assisted tonsillectomy and adenoidectomy, laser turbinate reduction, transoral laser microsurgery (TLM), nasal surgery, and other surgery types. The laser-assisted tonsillectomy and adenoidectomy segment held the largest share of the market in 2023.
Based on end-user, the laser-assisted ENT surgery market is categorized into hospitals and specialty clinics, physician office, and other end-users. The hospitals and specialty clinics segment held the largest share of the market in 2023.
Europe Laser-Assisted ENT Surgery Market Outlook
As healthcare systems worldwide increasingly prioritize outpatient care, the landscape of surgical interventions is evolving, with laser-assisted surgeries emerging as a preferred option for many ENT conditions. This shift is driven by several factors, including advancements in medical technology, patient preferences for convenience and reduced recovery times, and the economic benefits of outpatient procedures.
Lasers, such as carbon dioxide (CO2) lasers and Nd: YAG lasers, are widely used in various ENT surgeries, including the treatment of chronic sinusitis, tonsillectomies, and the removal of tumors. These lasers allow for precise tissue targeting, minimizing damage to surrounding areas and significantly reducing postoperative complications. As a result, many procedures that once required hospitalization can now be performed in outpatient settings, aligning with the growing preference for minimally invasive techniques.
Patients are increasingly seeking outpatient procedures due to the numerous advantages they offer. Outpatient surgeries typically involve shorter recovery times, allowing patients to return to their daily activities more quickly. This is particularly appealing in the fast-paced world, where individuals are often reluctant to take extended time off work or disrupt their personal lives for medical procedures. Laser-assisted surgeries, with their reduced recovery periods and lower risk of complications, fit perfectly into this demand. Patients appreciate the ability to undergo treatment and return home the same day, which enhances their overall experience and satisfaction with the healthcare system.
Furthermore, the shift toward outpatient procedures is influenced by changes in healthcare policies and reimbursement models. Many insurance providers now favor outpatient surgeries due to their cost-effectiveness and positive patient outcomes. This shift in reimbursement strategies encourages healthcare providers to adopt laser-assisted techniques, as they can offer high-quality care while meeting the financial incentives set forth by insurers. As reimbursement policies evolve, the laser-assisted ENT surgery market will likely benefit from increased adoption and utilization of these procedures.
As a result, the growing demand for outpatient procedures positively impacts the laser-assisted ENT surgery market.
Europe Laser-Assisted ENT Surgery Market Country Insights
Based on Geography, the Europe laser-assisted ENT surgery market comprises the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany held the largest share in 2023.
In Germany, laser surgery is becoming increasingly prominent as a preferred treatment option for various conditions affecting the ear, nose, and throat. Integrating advanced laser technologies into otolaryngology has revolutionized surgical practices, offering patients minimally invasive alternatives that result in quicker recovery and reduced complications. Biolitec is one of the prominent companies in Germany that are at the forefront of developing innovative laser systems designed explicitly for ENT applications. Its LEONARDO Mini Dual and LEONARDO Mini Blue lasers provide versatile solutions for a wide range of procedures in the head and neck area. These lasers utilize different wavelengths to achieve optimal results, allowing for precise tissue removal and effective treatment of ENT disorders, including tumors and chronic sinusitis.
Europe Laser-Assisted ENT Surgery Market Company Profiles
Some of the key players operating in the market include biolitec AG (Biolitec); Iridex Corporation; Medency; Dimed Laser Technology Co., Ltd.; intros Medical Laser GmbH; ARC Laser GmbH; LightScalpel; GIGAAMEDICAL; INTERmedic ARFRAN; Limmer Laser GmbH; Qolight Medical Laser; and Sisram Medical Ltd., among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
Europe Laser-Assisted ENT Surgery Market Research Methodology :
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:
Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise